Similarly, a study by Yu et al. (29) suggested that mortality was significantly greater in patients with T2DM who had COVID-19 and received insulin, compared with those who did not receive insulin (HR, 7.70; 95% CI, 4.22–14.05). This evidence concerns the gene INS and type 2 diabetes mellitus.